162 related articles for article (PubMed ID: 34145793)
1. Methylation of three genes encoded by X chromosome in blood leukocytes and colorectal cancer risk.
Tian T; Bi H; Zhang D; Liu Y; Sun H; Jia C; Zheng T; Huang H; Fu J; Zhu L; Zhao Y
Cancer Med; 2021 Jul; 10(14):4964-4976. PubMed ID: 34145793
[TBL] [Abstract][Full Text] [Related]
2. Methylation Status of Transcriptional Modulatory Genes Associated with Colorectal Cancer in Northeast China.
Gao HL; Wang X; Sun HR; Zhou JD; Lin SQ; Xing YH; Zhu L; Zhou HB; Zhao YS; Chi Q; Liu YP
Gut Liver; 2018 Mar; 12(2):173-182. PubMed ID: 29291617
[TBL] [Abstract][Full Text] [Related]
3. Methylation of a panel of genes in peripheral blood leukocytes is associated with colorectal cancer.
Luo X; Huang R; Sun H; Liu Y; Bi H; Li J; Yu H; Sun J; Lin S; Cui B; Zhao Y
Sci Rep; 2016 Jul; 6():29922. PubMed ID: 27453436
[TBL] [Abstract][Full Text] [Related]
4. Association between the methylation of CpG islands in JAK-STAT pathway-related genes and colorectal cancer.
Rong J; Pu R; Sun H; Liu Y; Tian T; Bi H; Xia T; Zhang L; Zhang Y; Zhao Y; Zhu L
Gene; 2023 Jun; 868():147357. PubMed ID: 36914143
[TBL] [Abstract][Full Text] [Related]
5. CHST7 Gene Methylation and Sex-Specific Effects on Colorectal Cancer Risk.
Bi H; Liu Y; Pu R; Xia T; Sun H; Huang H; Zhang L; Zhang Y; Liu Y; Xu J; Rong J; Zhao Y
Dig Dis Sci; 2019 Aug; 64(8):2158-2166. PubMed ID: 30815821
[TBL] [Abstract][Full Text] [Related]
6. Aberrant promoter methylation of PPP1R3C and EFHD1 in plasma of colorectal cancer patients.
Takane K; Midorikawa Y; Yagi K; Sakai A; Aburatani H; Takayama T; Kaneda A
Cancer Med; 2014 Oct; 3(5):1235-45. PubMed ID: 24861485
[TBL] [Abstract][Full Text] [Related]
7. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation of SFRP1, SFRP2, and WIF1 and prognosis of postoperative colorectal cancer patients.
Liu X; Fu J; Bi H; Ge A; Xia T; Liu Y; Sun H; Li D; Zhao Y
BMC Cancer; 2019 Dec; 19(1):1212. PubMed ID: 31830937
[TBL] [Abstract][Full Text] [Related]
9. PBX3 hypermethylation in peripheral blood leukocytes predicts better prognosis in colorectal cancer: A propensity score analysis.
Sun H; Huang H; Li D; Zhang L; Zhang Y; Xu J; Liu Y; Liu Y; Zhao Y
Cancer Med; 2019 Jul; 8(8):4001-4011. PubMed ID: 31140752
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory immune checkpoints PDCD-1 and LAG-3 hypermethylation may reduce the risk of colorectal cancer.
Zhang Y; Zhang L; Sun H; Liu Y; Xu J; Huang H; Fu J; Zhang D; Tian T; Zhao Y; Wang G
Mol Med; 2021 Sep; 27(1):114. PubMed ID: 34544358
[TBL] [Abstract][Full Text] [Related]
11. DNA Hypermethylation of SHISA3 in Colorectal Cancer: An Independent Predictor of Poor Prognosis.
Tsai MH; Chen WC; Yu SL; Chen CC; Jao TM; Huang CY; Tzeng ST; Yen SJ; Yang YC
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1481-9. PubMed ID: 25968618
[TBL] [Abstract][Full Text] [Related]
12. The specific methylation characteristics of cancer related genes in Chinese colorectal cancer patients.
Yang W; Wang X; Li X; Wang M; Chen X; Wu X; Wang Y; Fan Y; Jin H
Tumour Biol; 2014 Aug; 35(8):8267-79. PubMed ID: 24852431
[TBL] [Abstract][Full Text] [Related]
13. Relationship between DLEC1 and PBX3 promoter methylation and the risk and prognosis of gastric cancer in peripheral blood leukocytes.
Xie W; Zhou H; Han Q; Sun T; Nie C; Hong J; Wei R; Leonteva A; Han X; Wang J; Du X; Zhu L; Zhao Y; Tian W; Xue Y
J Cancer Res Clin Oncol; 2020 May; 146(5):1115-1124. PubMed ID: 32144534
[TBL] [Abstract][Full Text] [Related]
14. Association between hypermethylation of DNA repetitive elements in white blood cell DNA and early-onset colorectal cancer.
Walters RJ; Williamson EJ; English DR; Young JP; Rosty C; Clendenning M; Walsh MD; Parry S; Ahnen DJ; Baron JA; Win AK; Giles GG; Hopper JL; Jenkins MA; Buchanan DD
Epigenetics; 2013 Jul; 8(7):748-55. PubMed ID: 23804018
[TBL] [Abstract][Full Text] [Related]
15. Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas.
Zhang X; Song YF; Lu HN; Wang DP; Zhang XS; Huang SL; Sun BL; Huang ZG
World J Gastroenterol; 2015 Mar; 21(9):2629-37. PubMed ID: 25759530
[TBL] [Abstract][Full Text] [Related]
16. Promoter methylation of Wnt antagonists DKK1 and SFRP1 is associated with opposing tumor subtypes in two large populations of colorectal cancer patients.
Rawson JB; Manno M; Mrkonjic M; Daftary D; Dicks E; Buchanan DD; Younghusband HB; Parfrey PS; Young JP; Pollett A; Green RC; Gallinger S; McLaughlin JR; Knight JA; Bapat B
Carcinogenesis; 2011 May; 32(5):741-7. PubMed ID: 21304055
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor 2 hypermethylation in peripheral blood leukocytes and colorectal cancer risk and prognosis: a propensity score analysis.
Sun H; Liu Y; Zhang Y; Wang Y; Zhao Y; Liu Y
Front Oncol; 2023; 13():971435. PubMed ID: 37213278
[TBL] [Abstract][Full Text] [Related]
18. IGFBP3 methylation is a novel diagnostic and predictive biomarker in colorectal cancer.
Perez-Carbonell L; Balaguer F; Toiyama Y; Egoavil C; Rojas E; Guarinos C; Andreu M; Llor X; Castells A; Jover R; Boland CR; Goel A
PLoS One; 2014; 9(8):e104285. PubMed ID: 25127039
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation epigenotype and clinical features of NRAS-mutation(+) colorectal cancer.
Takane K; Akagi K; Fukuyo M; Yagi K; Takayama T; Kaneda A
Cancer Med; 2017 May; 6(5):1023-1035. PubMed ID: 28378457
[TBL] [Abstract][Full Text] [Related]
20. Multiple gene-specific DNA methylation in blood leukocytes and colorectal cancer risk: a case-control study in China.
Liu Y; Wang Y; Hu F; Sun H; Zhang Z; Wang X; Luo X; Zhu L; Huang R; Li Y; Li G; Li X; Lin S; Wang F; Liu Y; Rong J; Yuan H; Zhao Y
Oncotarget; 2017 Sep; 8(37):61239-61252. PubMed ID: 28977860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
